Walleye Trading
TXG icon

Walleye Trading’s 10x Genomics TXG Stock Holding History

Walleye Trading’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-36,868
Closed -$1.6M – 5517
2023
Q3 		$1.52M Buy
36,868
+18,088
+96% +$941K ﹤0.01% 2007
2023
Q2 		$1.05M Buy
+18,780
New +$1.02M ﹤0.01% 2130
2023
Q1 		– Sell
-205
Closed -$9.57K – 5429
2022
Q4 		$7.47K Buy
+205
New +$6.7K ﹤0.01% 4524
2021
Q3 		– Sell
-294
Closed -$58K – 5741
2021
Q2 		$58K Sell
294
-1,461
-83% -$264K ﹤0.01% 4577
2021
Q1 		$318K Sell
1,755
-1,446
-45% -$250K ﹤0.01% 3164
2020
Q4 		$453K Buy
3,201
+1,556
+95% +$226K ﹤0.01% 2741
2020
Q3 		$205K Buy
+1,645
New +$173K ﹤0.01% 2974

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Walleye Trading's TXG Position: Q4 2023 in Review

Walleye Trading sold out of 10x Genomics (TXG) in Q4 2023, closing a stake of 36,868 shares — an estimated $1.6M sold.

Walleye Trading first reported a position in TXG in Q3 2020 and held it in 7 quarters. The position peaked at $1.52M in Q3 2023. 275 funds tracked by Wall St. Rank hold TXG as of Q4 2023.

  • Walleye Trading reported no remaining 10x Genomics position as of Q4 2023 after selling out during the quarter.
  • Walleye Trading sold 36,868 10x Genomics shares in Q4 2023, an estimated $1.6M.
  • Walleye Trading first reported a position in 10x Genomics in Q3 2020 and held it in 7 quarters.
  • Walleye Trading's 10x Genomics position peaked at $1.52M in Q3 2023.
  • 275 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2023.

Based on Walleye Trading's 13F filing for Q4 2023, filed 14 Feb 2024.